- Home
- HSCS vs SYNX Comparison
HSCS vs SYNX Comparison
Compare HSCS & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- SYNX
- Stock Information
- Founded
- HSCS 2007
- SYNX 2005
- Country
- HSCS United States
- SYNX Israel
- Employees
- HSCS N/A
- SYNX N/A
- Industry
- HSCS Medical Specialities
- SYNX
- Sector
- HSCS Health Care
- SYNX
- Exchange
- HSCS Nasdaq
- SYNX Nasdaq
- Market Cap
- HSCS 9.9M
- SYNX 10.2M
- IPO Year
- HSCS 2022
- SYNX 2024
- Fundamental
- Price
- HSCS N/A
- SYNX $1.66
- Analyst Decision
- HSCS Strong Buy
- SYNX
- Analyst Count
- HSCS 2
- SYNX 0
- Target Price
- HSCS $10.50
- SYNX N/A
- AVG Volume (30 Days)
- HSCS 94.3K
- SYNX 107.9K
- Earning Date
- HSCS 09-11-2025
- SYNX 09-26-2025
- Dividend Yield
- HSCS N/A
- SYNX N/A
- EPS Growth
- HSCS N/A
- SYNX N/A
- EPS
- HSCS N/A
- SYNX N/A
- Revenue
- HSCS $6,250.00
- SYNX $6,003,000.00
- Revenue This Year
- HSCS $13,968.97
- SYNX $32.35
- Revenue Next Year
- HSCS $166.67
- SYNX N/A
- P/E Ratio
- HSCS N/A
- SYNX N/A
- Revenue Growth
- HSCS N/A
- SYNX N/A
- 52 Week Low
- HSCS $2.52
- SYNX $1.37
- 52 Week High
- HSCS $6.47
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- HSCS 53.94
- SYNX 57.80
- Support Level
- HSCS $3.57
- SYNX $1.37
- Resistance Level
- HSCS $3.80
- SYNX $1.74
- Average True Range (ATR)
- HSCS 0.17
- SYNX 0.09
- MACD
- HSCS 0.02
- SYNX 0.02
- Stochastic Oscillator
- HSCS 62.50
- SYNX 75.97
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.